Back to Directory

Paul Harding

Email

paul.harding@cuanschutz.edu

Phone

303-724 3404

Institution

University of Colorado-Anschutz Medical Center

Title

Address

University of Colorado-Anschutz Medical Center
12700 E. 19th Ave
Room # 11460-A

Aurora, CO 80045

Request an Update

Affiliated Studies

IMPAACT 2032: Pharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the United States

DAIDS Number

Research Area

Study Status

Participants Off Study and Primary Analysis Completed

P1113: AERAS-404 TB Vaccine in BCG-Primed Infants

DAIDS Number

Research Area

Study Status

Closed to Follow Up

IMPAACT 2021: Randomized Phase I/II Study of the Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV delta NS2/ delta 1313/I1314L, RSV 6120/ delta NS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age

DAIDS Number

Research Area

Cure and Immunotherapy

Study Status

Participants Off Study and Primary Analysis Completed

IMPAACT 2008: Phase I/II Multisite, Randomized, Controlled Study of Monoclonal Antibody VRC01 with Combination Antiretroviral Therapy to Promote Clearance of HIV-1-Infected Cells in Infants

DAIDS Number

Research Area

Cure and Immunotherapy

Study Status

Participants Off Study and Primary Analysis Completed

Show All